Calidi Biotherapeutics, Inc. (CLDI) stock
CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$0.53−0.03 (-5.79%)
Close on Nov 18, 2026Market cap $1.36MP/E –Yield –
Calidi Biotherapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Calidi Biotherapeutics's profit margin for the twelve months ending Dec 31, 2022 was -56504.4%. For fiscal 2022 it was -56504.4%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -56504.4% | – |
See a number that looks wrong?